Navitor Pharma

@NavitorPharma was also one of the first start-ups in @JLABS @LabCentral. We thank @jnjinnovation for its support of the #LifeSciences innovation ecosystem here and around the world! CC: @michalpreminger, @melindarichter Scott Orchard, Chris Picariello navitorpharma.com/about-us/a…

@NavitorPharma was one of the first start-ups in @JLABS @LabCentral. We thank @jnjinnovation for its support of the innovation ecosystem here and around the world!

@NavitorPharma is pleased to announce the acquisition of its spin-off, Anakuria Therapeutics, by @JanssenGlobal. #AnakuriaTx was formed to advance first-in-class selective #mTORC1 inhibitor AT-20494 for #ADPKD. businesswire.com/news/home/2….

On #WorldHealthDay we are wishing good health to everyone, and are grateful to the doctors, nurses and healthcare workers fighting to keep us healthy amidst #COVID19.

Women make up more than half the college-educated workforce, but only 28% of the #STEM workforce. Navitor supports industry efforts to increase this number and bring more women into our workplaces through efforts like: bit.ly/3aRInNg #InternationalWomenInScienceDay

Today, we honor and celebrate the life, legacy and dream of Dr. Martin Luther King, Jr., whose noble work and vision for a better future serves as an inspiration to all us at Navitor. #Diversity #Inclsuison #MLKDay

Thanks @PsychTimes for including NV-5138 in a recent round up of novel therapies for depression. See more here: psychiatrictimes.com/view/ps… @Supernus #mentalhealth #depression

During this holiday season we want to take a moment to recognize some silver linings that have come out of this tumultuous time. Never have we been more proud of the #biotech community that we are fortunate to be a part of. Enjoy!

Happy #Thanksgiving to colleagues, patients, and to our partners. We are thankful to be on this journey with you. #kidneydisease #HealthyAging

We had a great time speaking with @dslevine about the possibility of addressing multiple diseases through the modulation of mTORC1.

During #nationalfamilycaregiversmonth, we would like to express our gratitude to all the family members making an impact on patients’ lives around the world, especially during the COVID-19 pandemic. #CaregivingInCrisis

Thank you to @ASNKidney for an informative #KidneyWk 2020. We leave you with the factors that increase mTORC1 activity in the kidney; high exposure to glucose and insulin, hypertension, and the presence of abnormal protein variants including polycystin 1 (PKD1.) #kidneydisease

About 141,000 individuals in the US have autosomal dominant polycystic kidney disease (ADPKD), a monogenic multi-systemic disorder characterized by the development of renal cysts and various extrarenal manifestations. #KidneyWk #KidneyDisease

Today kicks off #KidneyWk 2020. DYK that mTORC1 is hyperactivated in autosomal dominant polycystic kidney disease (ADPKD)? #kidneydisease Learn more: navitorpharma.com/pipeline/n…

More important than ever to remember that tomorrow is National Depression Screening Day. @NavitorPharma we are committed to developing better treatments for #depression every day with our partner @Supernus_pharma. #ndsd #mentalhealth

Navitor recognizes #HealthyAgingMonth as a time to consider all that we can do to reduce the burden of chronic diseases and bring healthier years to us all as we age. How are we approaching the challenge? bit.ly/2YKLbqd

Happy #NationalCentenariansDay! There are all sorts of lessons to be learned from those who live to be 100. We are investigating the potential of modulating mTORC1 to address the underlying pathologies of age-related disease.

Chronological age matters less than ‘biological age’ for many conditions. Our Navalog platform enables specific modulation of mTORC1, the gatekeeper of cellular metabolism and renewal, addressing processes that underlie a wide range of age-related diseases. #healthyagingmonth